Skip to content
GK24

NPPA Cuts MRP of 1,364 Anti-Cancer Formulations from 9 November

Lower retail prices of 1,364 anti-cancer formulations took effect on 9 November 2026 after NPPA capped trade margins on 137 cancer drugs, saving Rs 3,540.38 crore.

By Published · 2 min read
NPPA Cuts MRP of 1,364 Anti-Cancer Formulations from 9 November

Why in News

On 9 November 2026 the revised maximum retail prices of 1,364 anti-cancer formulations came into effect, after the National Pharmaceutical Pricing Authority capped the trade margin on 137 anti-cancer drugs on the advice of a DGHS expert committee.

Cancer medicines became cheaper across the country on 9 November 2026. The National Pharmaceutical Pricing Authority (NPPA) has placed a ceiling on the trade margin that may be built into the maximum retail price of cancer drugs, and the reworked rates apply from that day. No chemist and no hospital pharmacy may now charge more than the new printed price.

Who took the decision

The authority functions under the Department of Pharmaceuticals in the Ministry of Chemicals and Fertilizers. Its order covers 137 anti-cancer drugs. It rests on the advice of an expert committee set up by the Directorate General of Health Services (DGHS) in the Ministry of Health and Family Welfare, whose recommendations are dated 17 October 2026.

How far the prices fell

Drug makers had to work out the new ceilings and report them to the regulator. By 8 November 2026, 85 pharmaceutical companies had filed revised retail prices for 1,364 anti-cancer formulations, which together cover 121 drugs. The cut crossed half the old price in 679 brands, and the steepest single reduction reported to the authority was 96.45 per cent. Adding up every reported cut, the regulator expects buyers of these medicines to be spared roughly Rs 3,540.38 crore in a year.

Drugs under the trade margin cap137
Formulations with revised prices1,364
Drugs these formulations cover121
Companies that reported85
Brands cheaper by over half679
Largest reduction reported96.45 per cent
Expected yearly savingRs 3,540.38 crore

What a patient should do

The revised rate is printed on the medicine pack, so the first check is the pack itself. The price can also be looked up on the Pharma Sahi Daam mobile app or on the NPPA website. If a shop or a hospital pharmacy bills more than the ceiling, the buyer can complain on the Pharma Jan Samadhan portal or ring the NPPA helpline on 1800-111-255.

Why the trade margin matters

A trade margin is the share of the retail price that is taken between the manufacturer and the counter. Capping it leaves the medicine itself unchanged but shrinks what is added on the way to the patient, which is why a single order was able to reduce prices in hundreds of brands at once. Cancer treatment usually runs over many months, so a lower ceiling on each pack keeps adding up for a family through the course of therapy.

Important Facts

RegulatorNational Pharmaceutical Pricing Authority (NPPA)
Comes underDepartment of Pharmaceuticals, Ministry of Chemicals and Fertilizers
Drugs under trade margin cap137 anti-cancer drugs
Formulations repriced1,364 formulations, covering 121 drugs
Companies reporting new prices85 pharmaceutical companies (as on 8 November 2026)
Brands cheaper by more than half679 brands
Steepest reduction reported96.45 per cent
Expected annual savingRs 3,540.38 crore
Revised prices effective from9 November 2026
Expert committeeSet up by the Directorate General of Health Services, Ministry of Health and Family Welfare; recommendations of 17 October 2026
Where to check the priceMedicine pack, Pharma Sahi Daam mobile app, NPPA website
Where to complainPharma Jan Samadhan portal or NPPA helpline 1800-111-255

Exam Point of View

Note the regulator (NPPA) and where it sits (Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers); the counts of 137 drugs capped, 1,364 formulations repriced, 121 drugs covered, 85 companies reporting and 679 brands cheaper by over half; the largest cut of 96.45 per cent; the yearly saving of Rs 3,540.38 crore; the effective date of 9 November 2026; the DGHS expert committee behind it; and the two consumer tools, the Pharma Sahi Daam app and the Pharma Jan Samadhan portal.

Practice Questions

Q2.EconomyMedium

Which authority capped the trade margins on the maximum retail price of 137 anti-cancer drugs?

  1. A.Central Drugs Standard Control Organisation
  2. B.Food Safety and Standards Authority of India
  3. C.National Pharmaceutical Pricing Authority
  4. D.Directorate General of Health Services
Show answer
Correct answer: C. National Pharmaceutical Pricing Authority

The NPPA works under the Department of Pharmaceuticals in the Ministry of Chemicals and Fertilizers, and it is the body that capped trade margins on the retail prices of 137 anti-cancer drugs, with the revised rates applying from 9 November 2026.

Frequently Asked Questions

How many anti-cancer formulations have become cheaper from 9 November 2026?

Revised maximum retail prices have been reported for 1,364 anti-cancer formulations, covering 121 drugs, by 85 pharmaceutical companies. The prices took effect on 9 November 2026 after NPPA capped the trade margin on 137 anti-cancer drugs.

How much will patients save because of the lower cancer drug prices?

The National Pharmaceutical Pricing Authority estimates the annual saving to consumers at about Rs 3,540.38 crore. In 679 brands the price fell by more than half, and the steepest reduction reported was 96.45 per cent.

Where can a patient verify the new price of a cancer medicine?

The revised maximum retail price is printed on the pack. It can also be checked on the Pharma Sahi Daam mobile app or the NPPA website. Overcharging by a chemist or a hospital pharmacy can be reported on the Pharma Jan Samadhan portal or on the NPPA helpline 1800-111-255.

Sources

Useful for:SSCSSC CGLIBPS